HomeFileStructural heart disease

Structural heart disease

View Category

Structural heart disease

NAVULTRA Registry: One-Year Outcomes of Self-Expanding vs. Balloon-Expandable Valves

In recent years, technological advances and increased operator experience have significantly contributed to improve transcatheter aortic valve...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

RHEIA Study: TAVR vs. SAVR for Severe Aortic Stenosis in Women

Severe aortic stenosis in women presents several differences compared to men, such as smaller aortic annuli, greater...
Dr. Carlos Fava -
Learn More
Structural heart disease

TAVR in Women

Severe aortic stenosis (AS) in women shows distinct features, compared to men, with lower prevalence of heart...
Dr. Carlos Fava -
Learn More
Left Atrial Apendix Closure

Early and Late Readmission after Left Atrial Appendage Closure

Percutaneous left atrial appendage closure (LAAC) represents an effective alternative for patients with atrial fibrillation and anticoagulation...
Dr. Juan Manuel Pérez -
Learn More
Structural heart disease

Impact of Tricuspid Regurgitation in Mitral V-in-V

The coexistence of mitral regurgitation (MR) and tricuspid regurgitation (TR) presents a therapeutic dilemma. While surgery is...
Dr. Carlos Fava -
Learn More
Other

Long-Term Outcomes of PFO Closure

Patent foramen ovale (PFO) is a recognized cause of cryptogenic stroke, and its closure via percutaneous treatment...
Dr. Carlos Fava -
Learn More
Structural heart disease

Post-TAVR Pacemaker Implantation in Aortic Regurgitation

Transcatheter aortic valve replacement (TAVR) has emerged as a therapeutic alternative to treat aortic regurgitation, especially in...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Heterotopic Treatment of the Tricuspid Valve

Tricuspid regurgitation (TR) has been associated to high morbimortality, mainly due to the development of cardiac failure,...
Dr. Carlos Fava -
Learn More